34046-43-0Relevant articles and documents
Cobalt(ii)-catalyzed benzylic oxidations with potassium persulfate in TFA/TFAA
Li, Tianlei,Li, Jishun,Zhu, Zihao,Pan, Weidong,Wu, Song
, p. 20879 - 20883 (2019/07/12)
A cobalt-catalyzed C(sp3)-H oxygenation reaction to furnish aldehyde was herein reported. This transformation demonstrated high chemo-selectivity, and tolerated various methylarenes bearing electron-withdrawing substituents. This reaction provided rapid access to diverse aldehydes form methylarenes. Notably, TFA/TFAA was used for the first time as a mixed solvent in cobalt-catalyzed oxygenation of benzylic methylenes.
Nickel-catalyzed reductive defunctionalization of esters in the absence of an external reductant: Activation of C-O bonds
Iyori, Yasuaki,Takahashi, Kenjiro,Yamazaki, Ken,Ano, Yusuke,Chatani, Naoto
supporting information, p. 13610 - 13613 (2019/11/14)
The nickel-catalyzed reductive cleavage of esters in the absence of an external reductant, which involves the cleavage of an inert acyl C-O bond in O-Alkyl esters is reported. Various groups, such as N-containing heterocycles, esters, amides, and even arene rings can function as a directing group.
METHYL OXAZOLE OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 35, (2016/06/28)
The present invention is directed to methyl oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.